Universität Wien

322013 UE Case Studies and Pharmaceutical Care - M9 (2025W)

(5 Kurse)

3.00 ECTS (3.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work

Anmeldung in 2 Schritten:
1. U:Space 322013 ( https://uspace.univie.ac.at/ )
UND
2. Anmeldesystem Pharmazie ( https://spl-pharmazie.univie.ac.at/anmeldesystemPHARMAZIE )
Moodle
Tu 18.11. 16:45-20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

Language: German

Lecturers

Classes (iCal) - next class is marked with N

Alle genauen Termine entnehmen Sie aus dem Moodle Kurs.

  • Tuesday 07.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 09.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 14.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 16.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 21.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 23.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 28.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 30.10. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 04.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 06.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 11.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 13.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 20.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 25.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 27.11. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 02.12. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 04.12. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 09.12. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 11.12. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Tuesday 16.12. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
  • Thursday 08.01. 16:45 - 20:00 UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
  • Tuesday 13.01. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
    UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
  • Tuesday 20.01. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
    UZA2 Hörsaal 8 (Raum 2Z206) 2.OG
  • Tuesday 27.01. 16:45 - 20:00 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
    UZA2 Hörsaal 8 (Raum 2Z206) 2.OG

Information

Aims, contents and method of the course

Based on the pharmacological knowledge already acquired, the students will deal in depth with the following topics in this exercise:

-) Principles of clinical-pharmaceutical care
-) Causes, symptoms, diagnosis and guideline-compliant therapy of various diseases, taking laboratory parameters into account
-) Identification of drug-related problems caused by potentially inadequate medication, including self-medication (drug interactions, side effects, application errors and adherence)
-) Dosage of drugs taking into account special patient needs

This exercise is offered in 3 modules with the following content:
-) Module 1: Introduction to medication analysis and laboratory diagnostics; hypertension
-) MODULE 2: Lung Diseases, Heart Failure and Myocardial Infarction
-) MODULE 3 - Atrial fibrillation and stroke prophylaxis; Thrombosis and embolism prophylaxis; Dyslipidemias
and Lipid Lowering Agents, Pharmaceutical Management of Diabetes Mellitus

The individual modules (1-3) each consist of introductory lectures, workshop units and an knowledge check on the subject matter covered. The lecture units are held. In the workshops you will work on and discuss case studies in small groups. These units are planned as face-to-face events.

You will receive the latest information during the semester.

The end of the exercise is a thesis with an examination character, whereby the knowledge acquired from all modules is applied here.

Assessment and permitted materials

-) Module 1-3: Participation and knowledge review (depending on the situation, possibly online via Moodle)
-) Complex case studies
-) Final thesis (depending on the situation, possibly online via Moodle)

Allowed aids during the units: guidelines, specialist information and interaction software

Minimum requirements and assessment criteria

▪ Presence (≥ 70%)
▪ Module 1-3: Participation and knowledge review or presentation (max. 10 points per module)
▪ Written thesis (max. 70 points)
The points achieved for the performances are added up, whereby at least half of the points to be achieved must be fulfield for each partial performance as well as for the final exam. The determined total number of points results in the overall grade.
Total possible number of points: 100 points
At least 50% (= at least 50 points) are required for a positive assessment.
Clef: 0-49.5 P. (5), 50-62 P. (4), 63-75 P. (3), 76-88 P. (2), 89-100 P. (1)

Examination topics

learning material taught in the course.

Reading list

- Clinical Pharmacy and Therapeutics (Walker, Clinical Pharmacy and Therapeutics); Cate Whittlesea BSc MSc PhD MRPharmS (Editor), Roger Walker BPharm PhD FRPharmS FFPH (Editor)
- Atkinson's Principles of Clinical Pharmacology; Shiew-Mei Huang (Herausgeber), Juan J.L. Lertora (Herausgeber), Paolo Vicini (Herausgeber),
- Applied Therapeutics (English Edition); Mary Anne Koda-Kimble (Autor, Herausgeber), Lloyd Yee Young

Auf weitere Literatur wird während der einzelnen Einheiten verwiesen.

Association in the course directory

A306, MA13

Last modified: Fr 19.09.2025 08:47